back insurance patient resources Covid-19 Response request records first visit info Common Clinical Fees billing inquiries pay bill

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Michael Narkewicz, MD

Physician

Board Certified

Schedule Appointment

Michael Narkewicz, MD

Physician

Board Certified

GENDER

Male

LANGUAGE

English, French

DEPARTMENT

Pediatrics

Specialty

Pediatrics, Pediatric Transplant Hepatology, Pediatric Gastroenterology

Primary Clinic Phone

(720) 777-6669

Locations

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Clinical Interest for Patients

I am nationally recognized for my expertise in pediatric hepatology and liver transplantation and cystic fibrosis liver disease. I have additional interests in chronic viral hepatitis, pediatric acute liver failure and chronic pancreatitis. I work closely with patients and families to find the best approaches to care to meet their needs.


Specialties

  • Pediatrics ( 1988 )
  • Pediatric Transplant Hepatology ( 2007 , 2017 )
  • Pediatric Gastroenterology ( 1990 , 2016 )

Conditions & Treatments

  • Digestive System

    Gastroenterology (Stomach, Bowel, General GI Problems), Hepatology (Liver Disorders)

  • Surgery

    Liver Transplant

Volunteer Activities

Round Up River Ranch volunteer physician. Medical Advisory Committee: Round Up River Ranch Chair, Medical Advisory Committee: American Liver Foundation


Medical Schools

MD, University of Vermont College of Medicine (1983)


Undergraduate Schools

AB, Dartmouth College (NH) (1979)


Residency Program

University of Colorado (1986)


Fellowships

University of Colorado (1989)

American Academy of Pediatrics (AAP), Fellow AAP


American Association for the Study of Liver Disease (AASLD), Fellow Member


American Pediatric Society, Member


North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), Member


Grants

Prospective Study of Hepatic US to Predict Cirrhosis In Cystic Fibrosis (2020)

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study) (2020)

A phase 2, open-label , multicenter, multi-cohort study to investigate the safety and efficacy of sofosbuvir/velpatasvir in adolescents and children with chronic HCV-infection (2020)

Pilot study of proteomics and metabolomics as part of the CFLD NET PUSH Longitudinal Study of Cystic Fibrosis Liver Disease. (2020)

CFF PUSH cohort analysis using MRI to characterize and predict CF liver disease (2020)

Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials (2020)

A Randomized Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection. (2020)


Research Interests for Patients

My research focuses on new therapies for children with hepatitis B and C. I lead a large study that is trying to develop tests that will predict which patients with cystic fibrosis are at risk for the development of advanced liver disease

information for referring providers

Clinical Interests for Referring Providers

I am interested in pediatric hepatology, liver transplantation, chronic viral hepatitis, pediatric acute liver failure, cystic fibrosis associated liver disease, and health care delivery.

Research Interest for Referring Providers

My research interests include clinical studies in children with biliary atresia, clinical trials and transmission in chronic viral hepatitis, hematologic and immunologic complications following pediatric liver transplantation, improved diagnosis and treatment of cystic fibrosis-associated liver disease, and clinical trials in acute liver failure.


Referral Contact Phone: 720-777-1234